FDA: opioid antidote naloxone recalled

June 6, 2018

(HealthDay)—A recall of the opioid overdose antidote Naloxone was announced Monday. The U.S. Food and Drug Administration said the recall was triggered by the possibility of "loose particulate matter on the syringe plunger" that could pose a number of health risks, CNN reported.

Those risks include "local irritation, allergic reactions," and a range of cardiovascular issues, including blood clots, according to the FDA. The agency has not received any reports of patient harm from the recalled Naloxone, made by Hospira.

The recall covers single use sterile cartridge units with lot numbers 72680LL and 76510LL in 0.4 mg/mL and 1 mL in 2.5 mL strengths that were distributed to wholesalers, distributors, and hospitals in the United States, Puerto Rico, and Guam between February 2017 and February 2018, CNN reported.

Hospira said distributors and retailers should not use or distribute the recalled Naloxone and should alert stores, pharmacies, and hospitals and others who have received it.

Explore further: Overdose antidote promotes stroke recovery in rats

More information: More Information

Related Stories

Overdose antidote promotes stroke recovery in rats

April 16, 2018
The life-saving drug used to treat opioid overdose, naloxone, reduces brain inflammation in the aftermath of stroke in male rats. The preclinical research, published in eNeuro, lays the groundwork for developing the first ...

Study: Wide distribution of naloxone can slash overdose deaths during epidemics

April 18, 2018
A new study in The Lancet Public Health shows the rapid expansion of British Columbia's Take Home Naloxone program significantly reduced the number of fentanyl-related overdose deaths in 2016.

Reversing opioid overdose: Concentrated naloxone nasal spray as good as injection

November 16, 2017
A new study published by the scientific journal Addiction has found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular ...

Let's talk about Rx use—recognizing and reversing an overdose

March 23, 2018
According to the National Institute on Drug Abuse, the misuse of and addiction to opioids is a serious national crisis, with more than 115 Americans dying from opioid overdose every day. Knowing how to prevent and recognize ...

Access to naloxone eased in Louisiana, Utah

February 13, 2017
(HealthDay)—Health officials in Utah and Louisiana have issued orders to make naloxone more widely available in an effort to prevent overdose deaths, according to a report from the American Medical Association.

How to obtain and use the 'angel' therapeutic Naloxone

July 18, 2017
It's a terrifying scenario that's become all-too-real in the age of the opioid epidemic: a person lying lifeless, not breathing, because of an opioid overdose.

Recommended for you

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.